NCT01105702View on ClinicalTrials.gov

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

PHASE2TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2015

Conditions
Brain Cancer
Interventions
DRUG

Temozolomide

DRUG

Bevacizumab

DRUG

Lithium Carbonate

RADIATION

Radiation

Trial Locations (2)

10016

New York University Clinical Cancer Center, New York

07902

Overlook Hospital, Summit

Sponsors
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Atlantic Health System

OTHER

lead

NYU Langone Health

OTHER